ARCHIVES

FDA Committee Agenda Includes M-AMSA, THC, Estramustine, Platinum

This article is from The Cancer Letter archive.

Vol. 07 No. 21 | May 22, 1981

Download PDF Visit The Full Archive

Related Articles

Kimmel Foundation To Donate $1 million for Cancer Research

June 28, 1996

FDA Grants Accelerated Approval To Mekinist-Tafinlar Combination

January 31, 2014

GI Intergroup called a model for proposed scientific steering committees.

June 10, 2005

Tyrosine Kinase Inhibitor Encoraging For NSCLC

July 27, 2001

White Heads NIH Legislative Policy Office

March 5, 2010

Maryland Contract Leafs New FY Awards

July 25, 1975